Neurology today by Conference Series: Enlightening the new scope in the field of Neurology
Singapore, London (PRWEB) October 27, 2018 -- Conference Series is effectively providing a helping hand to spread awareness in the field of neurology by joining hands with neurology societies. The Neurology conferences of the Conference Series aim to provide the latest information in neurology and healthcare by organizing medical and healthcare meetings across America, Europe and Asia in collaboration with 1000+ scientific societies.
The Conference Series holds its own unique meetings, events, exhibitions and rank among the world’s leading medical event organizers. It organizes different events in domains like Medical, Pharmaceutical, Engineering, Science, Technology and Business. The Conference Series has 50 million+ visitors, 25000+ unique visitors per conference and 75000+ page views. Participation in any of the conferences hosted by the Conference Series gives a platform to network and to get accessibility to the various online communities and get worldwide recognition.
Dr. Srinubabu Gedela, CEO of Omics International observed “Neurology conferences are a remarkable event, which bring together a unique international mix of large and medium medical and clinical research and diagnostic companies. He dubbed these conferences as a perfect platform to share experience, foster collaborations across industry and academia.”
Neurology today holds a root position in the various medical centers of the world. The study of neurology therefore has immense scope in today’s world. Many neurologists are taking additional training or interest in areas of neurology, such as stroke, epilepsy, neuromuscular, sleep medicine, pain management, or movement disorders. Neurology conferences aim to bring together all these experts in order to provide them with an opportunity to share and discuss the latest research focused at spreading awareness regarding the various neurological conditions.
Neurology represent the largest and untapped market in medicine sector as per the current estimated market analysis report which is based on the probability of approval and sales of products in late stage development, demographic trends and selling of product. Emerging markets once again help to boost revenues. CNS therapeutics comprise approximately 15% of the total pharmaceutical sales, nearly $30 billion worldwide. The estimated annual economic cost of anxiety disorders, depression, and schizophrenia is $47 billion, $44 billion, and $33 billion, respectively.
The Neurology conferences of the Conference Series aim to keep up their position in the scientific milieu by hosting a variety of neurology related conferences in 2019 directed towards fomenting further advances in neurology.
Abhishek Babu, PULSUS GROUP, http://www.pulsus.com, +91 4047482201, [email protected]
Share this article